cancer-therapy

Documents about cancer-therapy

• Photodynamic therapy based on indomethacin-conjugated photosensitizers: targeting cyclooxygenase-2 in cancer treatment#676330Europe PMC
• Comparison of the effects of exercise-based interventions on cardiometabolic health and fatigue in men with prostate cancer receiving androgen deprivation therapy: A network meta-analysis#127505Europe PMC
• A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy#329539ClinicalTrials.gov
• Advanced CD276-Targeting Dual-Payload Antibody-Drug Conjugates for Cancer Therapy.#122713NCBI PubMed Central
• Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes#123531ClinicalTrials.gov
• Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy#195303ClinicalTrials.gov
• Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever#208496ClinicalTrials.gov
• Application of artificial intelligence in lung cancer diagnosis, therapy, and prognosis.#219087NCBI PubMed Central
• MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)#230408ClinicalTrials.gov
• INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer#230432ClinicalTrials.gov
• Natural G-Quadruplex Stabilizers: A Targeted Strategy for Breast Cancer Therapy.#244276NCBI PubMed Central
• Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer#283105ClinicalTrials.gov
• Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC#307437ClinicalTrials.gov
• SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma#311183ClinicalTrials.gov
• Targeted Therapy and Avelumab in Merkel Cell Carcinoma#325300ClinicalTrials.gov
• Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus#385452PubMed Central
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma#390966ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Malignant Glioma#623518ClinicalTrials.gov
• Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases#633735ClinicalTrials.gov
• Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial#349967ClinicalTrials.gov
• Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy#28567ClinicalTrials.gov
• Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2#338826OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer#356470ClinicalTrials.gov
• Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy#460089ClinicalTrials.gov
• Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy#253368Dipòsit Digital de la Universitat de Barcelona
• Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer#279582ClinicalTrials.gov
• Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial#481743ClinicalTrials.gov
• Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy#121370ClinicalTrials.gov
• Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy#307466ClinicalTrials.gov
• A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer#369887ClinicalTrials.gov
• PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer#180392ClinicalTrials.gov
• Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer#245490ClinicalTrials.gov
• OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC#442103ClinicalTrials.gov
• A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer#467568ClinicalTrials.gov
• Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer#226326ClinicalTrials.gov
• Role of Total Neoadjuvant Therapy in Non-Metastatic Mid and Low Rectal Cancer. Experience of the Medical Oncology Department at the Pierre and Marie Curie Center, Algiers#427369HAL (France)
• HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis#230403ClinicalTrials.gov
• Prevalence of homologous recombination repair genes alterations in metastatic castration-resistant prostate cancer, a multicentric study#330213HAL (France)
• Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer#332741ClinicalTrials.gov
• Microbiota as a modulator of drug response: targeting microbial-drug crosstalk in cancer therapy#120198Europe PMC
• A prostate-specific membrane antigen targeted small molecule-drug conjugate for efficient prostate cancer therapy at a low dosage#5310Europe PMC
• Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)#121437ClinicalTrials.gov
• Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy#146472ClinicalTrials.gov
• Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models#154666ClinicalTrials.gov
• LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study#226236ClinicalTrials.gov
• The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer#268027ClinicalTrials.gov
• Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)#272352ClinicalTrials.gov
• LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials#291994IRIS
• A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis#329533ClinicalTrials.gov
• A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer#424179ClinicalTrials.gov